L089-0791 Screening compound: 4-tert-butyl-N-[(E)-N'-(2-ethylphenyl)-N-[2-(morpholin-4-yl)ethyl]carbamimidoyl]benzamide

L089-0791 Screening compound: 4-tert-butyl-N-[(E)-N'-(2-ethylphenyl)-N-[2-(morpholin-4-yl)ethyl]carbamimidoyl]benzamide
L089-0791 Screening compound: 4-tert-butyl-N-[(E)-N'-(2-ethylphenyl)-N-[2-(morpholin-4-yl)ethyl]carbamimidoyl]benzamide alternative view

Chemical Structure Depiction of ChemDiv screening compound L089-0791
4-tert-butyl-N-[(E)-N'-(2-ethylphenyl)-N-[2-(morpholin-4-yl)ethyl]carbamimidoyl]benzamide

Available from 1 mg

Formats:

  • Glass Vials (4ml Glass Vials VWR #97047-678)
  • 96-tube racks (Matrix #4247 96-well 1.4ml sealed with capmats, empty cols 1 & 12, 100uL of 10mM)

Shiptime: 1 week worldwide delivery in most cases

Compound Identifiers

ChemDiv Compound ID

L089-0791

Molecular Formula

C26H36N4O2 (C26 H36 N4 O2)

Compound Name

4-tert-butyl-N-[(E)-N'-(2-ethylphenyl)-N-[2-(morpholin-4-yl)ethyl]carbamimidoyl]benzamide

IUPAC name

4-tert-butyl-N-[(E)-N'-(2-ethylphenyl)-N-[2-(morpholin-4-yl)ethyl]carbamimidoyl]benzamide

SMILES

CCc(cccc1)c1/N=C(\NCCN1CCOCC1)/NC(c1ccc(C(C)(C)C)cc1)=O

InChI

InChI=1S/C26H36N4O2/c1-5-20-8-6-7-9-23(20)28-25(27-14-15-30-16-18-32-19-17-30)29-24(31)21-10-12-22(13-11-21)26(2,3)4/h6-13H,5,14-19H2,1-4H3,(H2,27,28,29,31)

InChI Key

SWWAFCCTIJDWNE-UHFFFAOYSA-N

MDL Number (MFCD)

MFCD27231504

Chemical and Physical Properties

Saltdata

n/a

Molecular Weight

436.6

Hydrogen Bond Acceptors Count

5.00

Hydrogen Bond Donors Count

2.00

Rotatable Bond Count

10.00

Number of Nitrogen and Oxygen Atoms

6

Partition Coefficient, logP

4.830

Distribution Coefficient, logD

3.686

Water Solubility, LogSw

-4.37

Polar Surface Area

52.886

Acid Dissociation Constant (pKa)

10.10

Base Dissociation Constant (pKb)

8.51

Number of Chiral Centers

0.00

Percent sp3 carbon bonding

46.20

L089-0791 in Drug Discovery

Included in Screening Libraries

Serine Proteases Inhibitors Library (32732 compounds)

Included in 1.7M Stock Database

Therapeutical areas:
  • Infections
  • Cancer
  • Musculoskeletal
  • Digestive system
  • Respiratory tract
  • Male
  • Female
  • Cardiovascular
  • Skin
  • Metabolic
  • Immune system
Targets:
  • Proteases

References: we are preparing a list of scientific research reports with L089-0791 chemical compound. It will be published here after verification.

Frequently Asked Questions

How to purchase chemical compound L089-0791?
Check Price and Availability of L089-0791, then you can add required amount to the Shopping Cart. In the Shopping Cart you can again refine your selection. Once you are sure that it’s exactly what you want you can move forward with the Checkout (to pay online by credit card, or via PayPal), or Request a Quote.
What is the minimum amount of L089-0791 you sell to drug discovery company or institution?
Available from 1 mg in Glass Vials or 96-tube racks.
Delivery options for L089-0791
ChemDiv sends parcels with Express services (UPS, WC).
  • 1–2 days for small orders
  • 2–4 weeks for large selections
Delivery formats for L089-0791
  • 0.5–50 mg of dry powder sample in single glass vials, custom vials
  • DMSO solutions frozen 10μl–250μl@10mM (96 and 384 format)

Custom synthesis of L089-0791 available by request